Hylan preparation and method of recovery thereof from animal tissues

• US 5,099,013 A
• Filed: 11/16/1990
• Issued: 03/24/1992
• Est. Priority Date: 03/12/1985
• Status: Expired due to Term

• Current Assignee: Biomatrix, Inc. (Sanofi )
• Original Assignee: Biomatrix, Inc. (Sanofi )
• Inventors: Band, Philip, Leshchiner, Adelya, Larsen, Nancy, Balazs, Endre A., Leshchiner, Adolf
• Primary Examiner(s): GRIFFIN, RONALD
• Application Number:
  US07/616,706
• Time in Patent Office: 494 Days
• Field of Search: 536/55.1, 435/267
• US Class Current: 536/55.1
• CPC Class Codes: C08B 37/0072 Hyaluronic acid, i.e. HA or hyaluronan; Derivatives thereof, e.g. crosslinked hyaluronic acid (hylan) or hyaluronates

Abstract

Disclosed is hylan, a chemically modified hyaluronan preparation characterized by the presence of small amounts (0.0002-0.05% by weight) of aldehyde cross-linking groups covalently bonded to the hyaluronan molecular chains. Also disclosed is an improved method of obtaining hylan comprising treating hyaluronan in situ in animal tissues containing same with a treatment mixture including an aldehyde which is reactive towards hyaluronic acid and the proteins contained in the animal tissue. Treatment is effected at temperatures below about 16° C. at very high pH, e.g., 8-14 whereby the overall yield is increased while maintaining the high molecular weight of the hylan.

Claims

1. A method of obtaining a chemically modified hyaluronic acid preparation comprising:

(a) treating animal tissue containing hyaluronic acid with an aqueous treating mixture including an aldehyde to effect chemical modification of the hyaluronic acid contained in the tissue, in situ,

(b) removing excess treating mixture from the reaction mixture,

(c) extracting the chemically modified hyaluronic acid from the treated animal tissue with water at a temperature below about 16°

C. and an alkaline pH of from 8 to 14 and beyond for about 6 hours to several days, the weight ratio of water to treated tissue being about 2-5;

1 based on the weight of the treated tissue,

(d) separating the extract containing the chemically modified hyaluronic acid from the treated animal tissue, and

(e) recovering the chemically modified hyaluronic acid from the extract.

2. A method according to claim 1 wherein the temperature is below about 5°

C.

3. A method according to claim 1 wherein the alkaline pH is achieved using an inorganic base, an organic base or mixtures thereof.

4. A method according to claim 3 wherein the base is an inorganic base.

5. A method according to claim 4 wherein the inorganic base is sodium hydroxide, potassium hydroxide, ammonium hydroxide, sodium carbonate or potassium carbonate.

6. A method according to claim 3 wherein the base is an organic base.

7. A method according to claim 6 wherein the organic base is triethylamine or triethanolamine.

8. A method according to claim 1 wherein the aldehyde is formaldehyde, glutaraldehyde or glyoxal.

9. A method according to claim 1 wherein the aqueous treating mixture includes a water-miscible solvent which does not react with the aldehyde.

10. A method according to claim 9 wherein the solvent is a lower ketone, a lower alcohol or an aprotic solvent.

11. A method according to claim 10 wherein the solvent is acetone, methyl ethyl ketone, ethanol, isopropanol, dimethyl formamide, dimethyl acetamide or dimethyl sulfoxide.

12. A method according to claim 9 wherein the weight ratio of water to water-miscible solvent in the treating mixture is 1-5:

4-8.5 and the weight ratio of water to aldehyde is 1-5;

0.02-1.

13. A method according to claim 9 wherein the aqueous treating mixture optionally includes an electrolyte and a water insoluble organic solvent.

14. A method according to claim 13 wherein the electrolyte is sodium acetate and the water insoluble organic solvent is chloroform.

15. A method according to claim 12 wherein the treating mixture comprises, in parts by weight:

space="preserve" listing-type="tabular">______________________________________ water 10-50 water-miscible solvent 40-85 aldehyde 0.2-10 water insoluble solvent 0.5-10 electrolyte 0-20 ______________________________________

16. A method according to claim 1 wherein the weight ratio of treating mixture to tissue to be treated is at least 10:

1, and treatment is effected for about 4-24 hours.

17. A method according to claim 1 wherein the animal tissue is rooster, chicken or hen combs and the combs are cut into slices of about 1-3 mm thickness.

18. A method according to claim 1 wherein excess treating mixture is removed from the reaction mixture by washing the treated tissue with a solvent or a solvent-water mixture.

19. A method according to claim 18 wherein the solvent used for washing the treated tissue is the same solvent as is used in the treating mixture.

20. A method according to claim 1 wherein the treated tissue is dried to about 25-50% of the treated weight before the extraction step.

21. A method according to claim 20 wherein drying is effected in air or nitrogen.

22. A method according to claim 1 wherein recovering is effected by precipitation with a quaternary ammonium compound.

23. A method according to claim 22 wherein the quaternary ammonium compound is cetyl pyridinium chloride.

24. A method according to claim 1 wherein the extract is separated from the animal tissue by filtration, centrifugation or decantation.

25. A method according to claim 24 wherein separation is effected by filtration.

26. A method according to claim 25 wherein the filtration is a two step procedure, a first, or gross filtration through a wide mesh to remove the pieces of animal tissue and a second, or fine filtration through a cellulosic material.

27. A method according to claim 1 wherein the chemically modified hyaluronic acid is recovered from the extract by precipitation with a solvent, followed by washing and drying the resulting precipitated chemically modified hyaluronic acid.

28. A method according to claim 27 wherein the solvent used for the precipitation is acetone, ethanol or isopropanol.

29. A method according to claim 28 wherein a mineral acid or an electrolyte is added during the precipitation step.

30. A method according to claim 29 wherein the mineral acid is HCl, H₂ SO₄ or H₃ PO₄ and the electrolyte is sodium acetate or NaCl.

31. A method according to claim 1 wherein the chemically modified hyaluronic acid is removed from the extract by lyophilization.

32. A method of cross-linking the chemically modified hyaluronic acid obtained according to the method of claim 1, which comprises subjecting said chemically modified hyaluronic acid to a cross-linking reaction with divinyl sulfone under alkaline conditions at room temperature for about one hour.

33. A method according to claim 1 and further comprising, washing said animal tissue in an uncut state with an inorganic alkali in an amount and concentration sufficient to create a pH of more than 12 for about 5 minutes to several hours, prior to the step of treating the animal tissue with the aqueous treating mixture.

34. A method according to claim 33 wherein the inorganic alkali is NaOH at a concentration of 0.05M to 4M.

35. A method according to claim 1 and further comprising neutralizing the excess alkali used in the extracting step by adding an acid to thereby render the preparation suitable for use in products requiring a substantially neutral pH.

36. A method according to claim 35 wherein the acid is an inorganic, organic or polymeric acid.

37. A method according to claim 36 wherein the acid is inorganic and is HCl, H₂ SO₄ or H₃ PO₄.

38. A method according to claim 36 wherein the acid is organic and is acetic, citric, stearic, palmitic, lauric, or p-aminobenzoic acid.

39. A method according to claim 36 wherein the acid is polymeric and is poly acrylic acid, poly methracylic acid, poly vinyl sulfonic acid or poly styrene sulfonic acid.

40. A cosmetic formulation containing a preparation obtained according to the method of claim 35.

41. A product produced by the method according to claim 1.

42. A product produced by the method according to claim 33.

43. A cross-linked product produced by the method according to claim 32.

44. A chemically modified hyaluronic acid preparation characterized by the presence of about 0.0002 to 0.05% by weight of aldehyde cross-linking groups covalently bonded to the hyaluronic acid polymer chains.

45. A preparation according to claim 44 which is sterile, non-inflammatory and pyrogen-free.